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Abstract 
Real-time monitoring of cellular and organ conditions improves our understanding of various 
physiopathological phenomena. Such monitoring is expected to provide important alterna-
tives for clinical diagnosis and therapy. We have sought to show physiopathological changes of 
organs as well as cells. Here, we present an example of in vivo imaging of liver states using the 
luciferase-based  caspase-3  optical  probe.  We  examined  dynamic  changes  of  apoptosis 
(caspase-3 activity) of a mouse liver as well as those of liver cells, proving that the emitted 
signals reflected the biochemically evaluated apoptotic cell death. In live liver cell (AML 12) 
experiments, the optical probe for caspase-3 activity emitted signals in response to Fas-ligand, 
staurosporine and hypoxia/reoxygenation, demonstrating that the probe can measure cellular 
apoptosis  quantitatively.  We  therefore  applied  this  probe  for  mouse  liver  ische-
mia/reperfusion (I/R) and drug-toxicity to liver. By expressing the probe in a mouse liver 
adenovirally, we imaged liver caspase-3 activity (i.e. apoptotic damage) non-invasively and 
chronologically in the hepatic I/R model of mice. The duration of liver ischemia affected the 
post-ischemic caspase-dependent damage. Ischemia (up to 60 min) enhanced liver damage 
after reperfusion, but prolonged ischemia (90 min of ischemia) induced not apoptotic cell 
death but necrotic cell death. Direct observations of the changes of organ conditions eluci-
dated the dynamism of organ function and damage. These technologies clearly possess clinical 
relevance. They are expected to provide a new diagnostic tool for various clinical settings in 
the future. 
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Introduction 
Real-time monitoring of cellular and organ con-
ditions  engenders  better  understanding  of  various 
phenomena.  Such  technologies  are  also  expected  to 
provide useful information as well as diagnostic and 
therapeutic options in various clinical settings. Many 
optical probes have been developed to visualize pro-
tease  activities  for  in  vivo  physiopathological  phe-
nomena imaging [1–7]. They have been used to ana-
lyze  the  dynamic  changes  of  cellular  and  organ 
damage, including hypoxia/reoxygenation (H/R) of 
cells and ischemia and reperfusion (I/R) of organs. 
Especially, I/R injury is an important concern in 
various clinical circumstances including organ trans-
plantation, myocardial infarction, and stroke. In these 
clinical  situations,  prolonged  ischemia  followed  by 
reperfusion  results  in  extended  organ  apopto-
sis/necrosis  and  organ  failure  [8].  Although  the 
mechanisms of I/R-induced tissue damage are com-
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plex, post-I/R apoptotic damage plays a pivotal role 
in  post-I/R  organ  failure  [9,  10].  Therefore, 
non-invasive monitoring of caspase-3 activity in vivo 
is  informative  and  is  likely  to  provide  important 
therapeutic information. 
We  previously  developed  a  novel  probe 
(pcFluc-DEVD)  of  cyclic  luciferase  reflecting  caspa-
se-3 activity [2]. Two fragments of DnaE inteins are 
fused to neighboring N-terminal and C-terminal ends 
of  firefly  luciferase  connected  with  a  substrate  se-
quence of caspase-3 (DEVD) (Fig. 1a). After transla-
tion  into  a  single  polypeptide,  the  N-terminal  and 
C-terminal ends  of luciferase are ligated by protein 
splicing,  producing  a  closed  circular  polypeptide 
chain.  The  cyclic  luciferase  structure  is  distorted. 
Therefore,  the  luciferase  loses  its  bioluminescence 
activity (inactive form). Once caspase-3 is activated in 
cells (DEVD is cleaved), Fluc changes into an active 
form if the substrate sequence is digested using the 
protease, thereby restoring luminescence activity (Fig. 
1b). 
Applicability  of  the  cyclic  luciferase  was  first 
demonstrated for quantitative detection of the caspa-
se-3  activities  in  living  cells.  The  probes  were  ex-
pressed in HeLa cells using a conventional plasmid 
transfection  technique  and  stimulated  with  stauro-
sporine. Cell-based analysis using the cyclic luciferase 
allowed for precise and quantitative measurements of 
caspase-3  activities  because  it  enabled  analysis  of  a 
statistically significant number of cells in a single as-
say  format.  The  response  of  cyclic  luciferase  upon 
caspase-3 activation was extremely rapid, suggesting 
high-throughput  screening  and  characterization  of 
therapeutic anticancer drugs and caspase inhibitors. 
Moreover,  the  cyclic  luciferase  enabled  in  vivo  re-
al-time imaging of caspase-3 activities in living mice. 
Chemical compounds, in many cases, are metabolized 
or chemically modified in living mice. Effective con-
centrations  of  the  chemical  compounds  can  be  esti-
mated noninvasively using this imaging method. 
Here, we present data related to in vitro meas-
urement of caspase-3 activity of live liver cells chal-
lenged by Fas-ligand (FasL), staurosporine (STS), and 
hypoxia, and also in vivo imaging of caspase-3 activity 
in post-ischemic liver using the caspase-3 probe. By 
transfecting  adenovirus  vectors  encoding 
pcFluc-DEVD  (AdpcFluc),  we  investigated  whether 
these probes will monitor redox states and apoptosis 
in live cells and liver during hypoxia/reoxygenation 
(H/R) and I/R in mice. We confirmed the efficacy of 
these probes in a mouse model and showed their po-
tential as clinical tools for additional applications. 
 
 
Figure 1. (a) Schematic structures of cDNA constructs. Fluc-N and Fluc-C indicate N-terminal and C-terminal fragments of 
Fluc. The Flanking sides of the luciferase are connected with C-terminal and N-terminal fragments of DnaE (DnaEc and 
DnaEn). A PEST sequence is attached at the C-terminal end to decompose the unspliced product. (b) Principle for moni-
toring activity of caspase-3 using cyclic firefly luciferase. Theranostics 2012, 2(2) 
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Figure 2. (a) Measurement of staurosporine-induced Caspase-3 activity: time course (activity in cell lysates). (b) Meas-
urement of staurosporine-induced Caspase-3 activity: dose response (activity in cell lysates). (c) Comparison of stauro-
sporine-induced Caspase-3 activity (live cells) and apoptosis. Results are expressed as mean ± s.e.m. of five independent 
experiments. A P-value <0.05 was inferred as significant. 
 
 
In vitro measurement of cellular apoptosis in 
AML12 liver cells challenged by staurosporine 
and Fas-ligand 
STS and Fas ligand respectively activate caspa-
se-3 caspase-8-independently and dependently. First, 
we  measured  caspase-3  activity  in  cell  lysates  pre-
pared  from  STS-challenged  AML12  cells  that  had 
been  transiently  transfected  with  caspase-3  probe 
(pcFluc-DEVD) (Fig. 2a). The 2.5 μM STS immediately 
induced caspase-3 activity and continued for at least 
2.5 hr (peak value at 2 hr), although untreated cells 
showed only basal level signals. In fact, 1, 3, and 10 
μM of STS also induced caspase-3 activity in AML12 
liver cells, with a peak value at the concentration of 3 
μM (Fig. 2b). Therefore, we checked the relations be-
tween STS-induced caspase-3 activity and apoptosis 
(Fig. 2c). Signals from the probe started to increase 
immediately after STS administration to AML12 cells. 
They peaked at 2 hr and gradually returned to basal Theranostics 2012, 2(2) 
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levels  thereafter.  The  decrease  in  the  luminescence 
after peaking at 2 hr might originate from decompo-
sition of the probe, decreasing the ATP or the sub-
strate D-luciferin. In accordance with caspase-3 acti-
vation,  cellular  apoptosis  occurred  4  hr  after 
STS-treatment  and  continued  to  increase  until  8  hr 
post-treatment. These data indicate the biological ac-
curacy of caspase-3 activity indicated by our probe. 
Clinically, Fas has been shown to be important in 
hepatitis and other liver diseases [11–13]. The liver is 
extremely  sensitive  to  Fas-mediated  apoptosis  be-
cause  Fas  antigen  is  expressed  constitutively  on 
hepatocytes. The  Fas/FasL system is apparently in-
volved  in  many  pathological  situations  such  as 
graft-versus-host disease, liver transplant, hepatitis B 
and  C,  acute  alcoholic  hepatitis,  and  some  biliary 
diseases  [11,  12,  14].  Fas  stimulation  by  Fas-ligand 
(CD95/Apo-1,  Jo2  antibody  as  a  mouse  Fas-ligand) 
activates caspase-3 via caspase-8 in liver cells. Then 1 
μg/ml or 2 μg/ml of Jo2 antibody activated caspase-3 
by cleaving inactive pro-caspase-3 into the active form 
of caspase-3 (Fig. 3a) in mice liver cells. AML12 liver 
cells  transfected  with  pcFluc-DEVD  emitted  signals 
by  Jo2  administration.  The  signals  were  observed 
immediately  after  Jo2  treatment;  subsequently  they 
peaked at 3–4 hr, and returned gradually to the basal 
levels by 8–10 hr (Fig. 3b).  
 
 
Figure  3.  (a)  Binding  of 
Fas-ligand  (Jo-2)  to 
Fas-activated  caspase-3  (in-
crease  of  cleaved  caspase-3). 
(b)  Measurement  of 
Fas-L-induced caspase-3 activ-
ity in live liver cells. (c) Com-
parison  of  FasL-induced 
caspase-3  activity  (live  cells) 
and apoptosis in AML12 liver 
cells. 
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It is particularly interesting that the peak values 
(the caspase-3 activity intensity) were not suppressed 
by the administration of a general caspase inhibitor, 
Z-BAD-FMK,  but  were  simply  delayed  about  4  hr, 
maintaining  equal  peak  values.  These  data  suggest 
that Z-BAD-FMK does not suppress caspase reactions: 
it merely retards the cascade reactions of caspases. To 
confirm  the  biological  activity  of  caspase-3  in 
FasL-challenged AML12 cells, we also studied apop-
totic cell death as well as caspase-3 activity. In Fas-L 
treated cells, caspase-3 activity was induced immedi-
ately after the treatment and paralleled with apoptotic 
cell death (Fig. 3c). 
In vitro evaluation of cellular apoptosis by 
caspase-3 activity in post-hypoxic AML12 liver 
cells 
During hypoxia of AML12 liver cells, the caspa-
se-3  signals  dropped  to  minimal  levels  because  of 
rapid loss of cellular ATP (Fig. 4). The signals recov-
ered  rapidly  to  the  basal  levels  after  reoxygenation 
and rose until 4–6 hr post-H/R. 
These data indicate that our probe is applicable 
to various biological systems. In the experiments de-
scribed hereinafter, we applied this probe as a marker 
of apoptotic cell death in in vivo as well as in vitro ex-
periments. 
In vivo evaluation of liver apoptosis by caspase-3 
activity in hepatic ischemia/reperfusion (I/R) 
model 
Adenovirus  vector  encoding  caspase-3  probe 
(AdpcFluc-DEVD) was injected intravenously 3 days 
before the experiment (5 × 107 pfu/body). Liver is-
chemia was obtained by clamping all vessels (hepatic 
artery, portal vein, and bile duct) to the left and me-
dian  liver  lobes.  After  liver  ischemia,  these  vessels 
were  unclamped  for  hepatic  reperfusion.  Then 
D-luciferin, a luciferase substrate, was injected intra-
peritoneally at a dose of 3 mg/100 μl in PBS. In vivo 
imaging of the mouse liver was performed using an in 
vivo imager for 5 min, from 5–10 min after injection 
[15]. 
The  pcFluc-DEVD  probe  indicated  dynamic 
changes of liver damage chronologically and quanti-
tatively  by  visualizing  caspase-3  activity  in  the 
post-ischemic  liver  (Fig.  5a).  Caspase-3  activity,  i.e. 
cellular apoptosis, increased 2–6 hr after reperfusion 
of  the  liver  and  gradually  decreased  until  24  hr  in 
30-min post-ischemic liver. Actually, 60-min ischemia 
showed a great increase of caspase-3 activity (apop-
totic liver damage) at the later time point (6–9 hr). It is 
particularly  interesting  that  prolonged  ischemia  (90 
min of ischemia) did not induce apoptotic cell death. 
Instead, necrotic cell death increased significantly, as 
assessed by serum levels of GPT /LDH (Fig. 5b).  
 
 
 
Figure 4. Hypoxic insult induced activation of caspase-3 in AML12 liver cells. Compared to the control cells without 
hypoxia (black line), optical signals dropped during hypoxia. They recovered to the baseline and rapidly increased after 
reoxygenation (gray line). 
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Figure 5. (a) Ischemic insult to liver induced caspase-3 activation. (lt. and middle liver ischemia and reperfusion). (b) Serum 
levels of GPT and LDH (necrotic markers of liver) 6 hr after hepatic I/R. At least three mice were used for each experiment. 
The photographs are representative of three independent experiments. Data are expressed as mean ± s.e.m. 
 
 
These  data  revealed  time–strength  relations  of 
post-ischemic apoptotic damage in the liver, and also 
might provide more information and some patholog-
ical  insight  into  I/R-induced  liver  damage.  Longer 
liver ischemia might not simply give stronger dam-
age, but persistent damage to the post-ischemic liver 
by  continued  activation  of  caspases  (apoptosis) 
and/or  by  necrosis.  However,  prolonged  ischemia 
induced cell death directly by necrosis, not by apop-
tosis. 
Discussion 
The  optical  probe  for  caspase-3  activity  probe 
detected cellular/organ apoptotic cell death in vari-
ous conditions, which clearly illustrated liver damage 
by  I/R  in  mouse  liver.  The  prolonged  ischemia  in-
duced profound liver damage by persistent apoptotic 
damage with a peak at a later time point. These data 
undoubtedly present the possibility of these probes in 
the analysis and understandings of physiopathologi-
cal  conditions  in  vivo.  In  many  surgical  treatments 
such as cell/organ transplantation and surgical resec-
tion of the pathological organs, H/R or I/R are una-
voidable  events.  Probes  of  this  kind  will  definitely 
provide, intra-operatively and also post-operatively, 
important information of cell and organ conditions, 
allowing a prediction about the current cell and organ 
damage and viability and functional failure at later 
time points. 
Bio-probes of these kinds showing apoptosis and 
other  cellular  phenomena/conditions  1)  might  pro-
vide useful tools to discover new drugs and to avoid 
their side effects, 2) might enable personalized drug 
therapy by showing drug effects in patients, and 3) 
might  support  selection  of  the  best  drugs  for  each 
patient by pre-checking drug effects ex vivo. Thereby, 
biological probes of this kind will possess potential 
clinical relevance as a new diagnostic and therapeutic 
tool.  Caspase  probes  revealed  apoptotic  damage  in 
vitro and in vivo. By showing cell and organ condi-
tions, these might provide many options for future for 
future diagnoses. 
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Materials and Methods 
AML12 liver cells, adenovirus vector (AdpcFluc) 
and reagents 
Alpha  mouse  liver  12  (AML12)  cells  (ATCC, 
Manassas, VA), established from hepatocytes from a 
mouse  transgenic  for  human  transforming  growth 
factor-α (TGF-α), express high levels of human TGF-α 
and  lower  levels  of  mouse  TGF-α.  Replica-
tion-deficient  recombinant  adenovirus-encoding 
pcFluc-DEVD (AdpcFluc) were generated in our la-
boratory  and  transfected  into  AML12  cells  at  five 
multiplicities  of  infection  (moi)  or  injected  to  mice 
intravenously  (5  ×  107  pfu/body)  at  48  hr  or  72  hr 
before the experiment. To examine basic functions of 
the caspase-3 optical probe, homogenates of AML12 
cells (2 × 105 / 3.5 cm Dish) challenged with stauro-
sporine  (STS)  were  applied  for  in  vitro  cell-free 
bio-luminescence activity assay. Briefly, 1–10 μM of 
STS  was  administered  in  AML12  cells.  Cells  were 
harvested  sequentially  and  their  caspase-3  activity 
was measured (Bright-Glo Luciferase Assay System, 
GloMax®-20/20  Luminometer;  Promega  Corp.). 
D-luciferin K salt was purchased (Dojindo Laborato-
ries,  Japan).  All  other  chemicals  were  of  analytical 
grade and were used without further purification. 
Measurements of bio-luminescence activity for 
caspase-3 in live cells and apoptosis challenged by 
H/R or Fas ligand (FasL) 
To obtain cellular hypoxic conditions, cells were 
ventilated by continuous gas flow with a 95% N2=5% 
CO2 gas mixture (150 ml/min). This method has been 
shown  to  achieve  a  pO2  of  10  ×  5  Torr  (where  1 
Torr.0.133 kPa) within 2 min. After hypoxia of AML12 
cells,  reoxygenation  was  achieved  by  flushing  con-
tinuously with a 95% air/ 5% CO2 gas mixture. After 
adding D-luciferin substrate (1mM), bioluminescence 
for  caspase-3  activity  in  live  cells  during  H/R  or 
stimulated  by  FasL  was  measured  chronologically 
(Kronos-Dio;  Atto  Corp.,  Tokyo,  Japan).  Apoptotic 
cell death was measured using a kit (Cell Death Elisa; 
Roche, Switzerland) according to the manufacturer’s 
instructions to ensure the accuracy of this probe as an 
apoptotic marker. 
In vivo imaging of mouse liver challenged with I/R 
Male  C57Black/6  mice,  8–10  weeks  old,  were 
starved overnight before use. Three days before each 
experiment,  adenovirus  vector  coding  for 
pcFluc-DEVD  (Ad  pcFluc-DEVD)  was  administered 
intravenously (iv) via the tail vein in a volume of 100 
μl  (5  ×  107  pfu/body)  using  a  31G  needle.  General 
anesthesia was induced with the inhalation anesthetic 
methoxyflurane  (Metofane);  heparin  sulfate  (100 
U/kg body weight) was injected intravenously. After 
laparotomy,  all  vessels  (hepatic  artery,  portal  vein, 
and bile duct) to the left and median liver lobes were 
clamped.  After  30–60  min  of  liver  partial  ischemia, 
these vessels were unclamped. Then the hepatic cir-
culation  was  restored  for  the  specified  reperfusion 
period. D-luciferin was injected intraperitoneally at a 
dosage of 3 mg/100 μl in PBS. In vivo imaging of the 
mouse liver was performed using an in vivo imager 
for 5 min from 5–10 min after injection by a Photon 
Imager (Biospace Lab, Paris, France). 
Statistical Analysis 
Results were expressed as mean ± s.e.m. Statis-
tical  analyses  were  performed  using  Fisher’s  test; 
P-values <0.05 were considered significant. 
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